| 01-30-2012 05:00 AM CET - Politics, Law & Society |
|
Bristol-Meyers Squibb Sued by 72 Plaintiffs Over Plavix Side Effects
Press release from: Nadrich & Cohen LLP
(openPR) - Nadrick & Cohen, LLP reports that 72 plaintiffs have joined together in a Plavix side effects lawsuit filed against Bristol-Meyers Squibb.
Los Angeles, CA, January 27, 2012 – Seventy-two plaintiffs from across the country have joined together in filing a Plavix side effects lawsuit against the drug’s maker, Bristol-Meyers Squibb. According to the Madison Record, the plaintiffs are seeking an unspecified amount of compensation for injuries they say were caused by the drug.
The lawsuit, filed in an Illinois circuit court, includes plaintiffs from a number of states, including Ohio, California, Louisiana, New York and Connecticut. The plaintiffs allege that Plavix caused heart attacks, strokes, internal bleeding and other serious complications. The lawsuit also claims that Bristol-Meyers and co-defendant Sanofi Aventis marketed the drug inappropriately and failed to adequately warn consumers of the potential dangers.
Plavix (clopidogrel) was first approved by the U.S. Food and Drug Administration in 1997 for the prevention of heart attack and stroke. The drug was touted as being more effective and safer in reducing the risk of cardiovascular complications compared to a daily aspirin regimen.
In 2010, the FDA issued a new black box warning label for Plavix, advising health care professionals and patients that the drug’s effectiveness may be reduced for patients with a specific genetic variant. A new study published in 2011 suggested that the genetic test may not be as significant as previously thought in determining the drug’s effectiveness.
Patients who experienced complications after taking Plavix are urged to complete a MedWatch form by visiting the Food and Drug Administration’s website. It is also recommended that you contact an experienced personal injury lawyer to discuss your rights.
Nadrich & Cohen LLP offers confidential, no-cost consultations to Plavix users who believe they were harmed by the drug. Help is available by calling the firm’s injury hotline at 1-800-722-0765 or by completing an online case evaluation form at www.personalinjurylawcal.com.
Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California. The firm specializes in handling mass tort actions and representing individuals in cases involving pharmaceutical companies, medical device makers and other product manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.
In addition to handling Plavix side effects claims, Nadrich & Cohen, LLP investigates cases involving Accutane, Avandia, DePuy Hip Implants, Zimmer Hips, Wright Conserve Hips, Vaginal Mesh, Pradaxa, Stevens-Johnson Syndrome, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan. All cases are accepted on a contingency basis, meaning there is never a fee unless we recover a judgment on your behalf. The time you have to file an injury claim is limited, so it’s important that you act quickly to protect your rights.
Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com
Los Angeles, CA, January 27, 2012 – Seventy-two plaintiffs from across the country have joined together in filing a Plavix side effects lawsuit against the drug’s maker, Bristol-Meyers Squibb. According to the Madison Record, the plaintiffs are seeking an unspecified amount of compensation for injuries they say were caused by the drug.
The lawsuit, filed in an Illinois circuit court, includes plaintiffs from a number of states, including Ohio, California, Louisiana, New York and Connecticut. The plaintiffs allege that Plavix caused heart attacks, strokes, internal bleeding and other serious complications. The lawsuit also claims that Bristol-Meyers and co-defendant Sanofi Aventis marketed the drug inappropriately and failed to adequately warn consumers of the potential dangers.
Plavix (clopidogrel) was first approved by the U.S. Food and Drug Administration in 1997 for the prevention of heart attack and stroke. The drug was touted as being more effective and safer in reducing the risk of cardiovascular complications compared to a daily aspirin regimen.
In 2010, the FDA issued a new black box warning label for Plavix, advising health care professionals and patients that the drug’s effectiveness may be reduced for patients with a specific genetic variant. A new study published in 2011 suggested that the genetic test may not be as significant as previously thought in determining the drug’s effectiveness.
Patients who experienced complications after taking Plavix are urged to complete a MedWatch form by visiting the Food and Drug Administration’s website. It is also recommended that you contact an experienced personal injury lawyer to discuss your rights.
Nadrich & Cohen LLP offers confidential, no-cost consultations to Plavix users who believe they were harmed by the drug. Help is available by calling the firm’s injury hotline at 1-800-722-0765 or by completing an online case evaluation form at www.personalinjurylawcal.com.
Nadrich & Cohen LLP is a national law firm with offices in Los Angeles, Sacramento, San Diego and other cities throughout California. The firm specializes in handling mass tort actions and representing individuals in cases involving pharmaceutical companies, medical device makers and other product manufacturers. The firm is committed to achieving the best outcome possible in every case and has recovered over $200 million in settlements on behalf of its clients.
In addition to handling Plavix side effects claims, Nadrich & Cohen, LLP investigates cases involving Accutane, Avandia, DePuy Hip Implants, Zimmer Hips, Wright Conserve Hips, Vaginal Mesh, Pradaxa, Stevens-Johnson Syndrome, Reflex Sympathy Dystrophy, Fen Phen and PPH, Depakote and Reglan. All cases are accepted on a contingency basis, meaning there is never a fee unless we recover a judgment on your behalf. The time you have to file an injury claim is limited, so it’s important that you act quickly to protect your rights.
Jennifer Poole
National Client Intake Coordinator
Nadrich & Cohen LLP
12100 Wilshire Blvd.
Suite 1250
Los Angeles, CA 90025
800-718-4658
info@personalinjurylawcal.com
www.personalinjurylawcal.com
News-ID: 208823
More releases
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
Please set a link in the press area of your homepage to this press release on openPR.
openPR disclaims liability for any content contained in this release.
© openPR 2012 | Imprint
More Releases from
Nadrich & Cohen LLP
Comments about openPR
We publish our press releases on openPR.de because we like people who are "open" - just like us.
Frank Obels, CEO, INCONET - Informationssysteme, Communication und Netzwerkberatung GmbH
Frank Obels, CEO, INCONET - Informationssysteme, Communication und Netzwerkberatung GmbH

